(5)

Chapter 26 is amended as follows: (a) point II.1.11 of the public health attestation is replaced by the following: ‘(1) [II.1.11. if containing material from bovine, ovine or caprine animals, with regard to bovine spongiform encephalopathy (BSE): (1) either [the country or region of origin is classified in accordance with Commission Decision 2007/453/EC (M) as a country or region posing a negligible BSE risk, and (1) either [the animals from which the meat products are derived were born, continuously reared and slaughtered in a country or region classified in accordance with Decision 2007/453/EC as a country or region posing a negligible BSE risk in which there have been no BSE indigenous cases;] (1) or [the animals from which the meat products are derived originate from a country or region classified in accordance with Decision 2007/453/EC as a country or region posing a negligible BSE risk in which there has been at least one BSE indigenous case, and the meat products do not contain and are not derived from mechanically separated meat obtained from bones of bovine, ovine and caprine animals;] (1) or [the animals from which the meat products are derived originate from a country or region classified in accordance with Decision 2007/453/EC as a country or region posing a controlled BSE risk and: (i) the meat products do not contain and are not derived from specified risk material as defined in Annex V, point 1, to Regulation (EC) No 999/2001; (ii) the meat products do not contain and are not derived from mechanically separated meat obtained from bones of bovine, ovine and caprine animals; (iii) the animals from which the meat products are derived have not been slaughtered after stunning by means of gas injected into the cranial cavity or killed by the same method or slaughtered by laceration after stunning of central nervous tissue by means of an elongated rod-shaped instrument introduced into the cranial cavity;] (1) or [the animals from which the meat products are derived originate from a country or region classified in accordance with Decision 2007/453/EC as a country or region posing an undetermined BSE risk and: (i) the meat products do not contain and are not derived from specified risk material as defined in Annex V, point 1, to Regulation (EC) No 999/2001; (ii) the meat products do not contain and are not derived from mechanically separated meat obtained from bones of bovine, ovine and caprine animals; (iii) the animals from which the meat products are derived have not been slaughtered after stunning by means of gas injected into the cranial cavity or killed by the same method or slaughtered by laceration after stunning of central nervous tissue by means of an elongated rod-shaped instrument introduced into the cranial cavity;] (iv) the animals from which the meat products are derived have not been fed with meat-and-bone meal or greaves, as defined in the Terrestrial Animal Health Code of the World Organisation for Animal Health (N); (v) the meat products were produced and handled in a manner which ensures that they do not contain and were not contaminated with nervous and lymphatic tissues exposed during the deboning process;]] (1) or [the country or region of origin is classified in accordance with Decision 2007/453/EC as a country or region posing a controlled BSE risk, and (a) the animals from which the meat products are derived have not been slaughtered after stunning by means of gas injected into the cranial cavity or killed by the same method or slaughtered by laceration after stunning of central nervous tissue by means of an elongated rod-shaped instrument introduced into the cranial cavity; (1) either [(b) the meat products do not contain and are not derived from: (i) specified risk material as defined in Annex V, point 1, to Regulation (EC) No 999/2001; (ii) mechanically separated meat obtained from bones of bovine, ovine and caprine animals.] (1) or [(b) the meat products contain and are derived from treated intestines sourced from animals which were born, continuously reared and slaughtered in a country or region classified in accordance with Decision 2007/453/EC as a country or region posing a negligible BSE risk in which there have been no BSE indigenous cases;] (1) or [(b) the meat products contain and are derived from treated intestines sourced from animals which originate from a country or region classified in accordance with Decision 2007/453/EC as a country or region posing a negligible BSE risk in which there has been at least one BSE indigenous case, and: (1) either [(i) the animals were born after the date from which the ban on the feeding of ruminants with meat-and-bone meal and greaves derived from ruminants has been enforced;] (1) or [(i) the treated intestines of bovine, ovine and caprine animal origin do not contain and are not derived from specified risk material as defined in Annex V, point 1, to Regulation (EC) No 999/2001.]] (1) either [(c) the animals from which the meat products are derived originate from a country or region classified in accordance with Decision 2007/453/EC as a country or region posing a negligible or a controlled BSE risk;] (1) or [(c) the animals from which the meat products are derived originate from a country or region classified in accordance with Decision 2007/453/EC as a country or region posing an undetermined BSE risk and (i) the animals from which the meat products are derived have not been fed with meat-and-bone meal or greaves, as defined in the Terrestrial Animal Health Code of the World Organisation for Animal Health; (ii) the meat products were produced and handled in a manner which ensures that they do not contain and were not contaminated with nervous and lymphatic tissues exposed during the deboning process;]] (1) or [the country or region of origin is classified in accordance with Decision 2007/453/EC as a country or region with an undetermined BSE risk, and (a) the animals from which the meat products are derived have not been: (i) slaughtered after stunning by means of gas injected into the cranial cavity or killed by the same method or slaughtered by laceration after stunning of central nervous tissue by means of an elongated rod-shaped instrument introduced into the cranial cavity; (ii) fed meat-and-bone meal or greaves derived from ruminants, as defined in the Terrestrial Animal Health Code of the World Organisation for Animal Health; (1) either [(b) the meat products do not contain and are not derived from: (i) specified risk material as defined in Annex V, point 1, to Regulation (EC) No 999/2001; (ii) mechanically separated meat obtained from bones of bovine, ovine and caprine animals; (iii) nervous and lymphatic tissues exposed during the deboning process.] (1) or [(b) the meat products contain and are derived from treated intestines sourced from animals which were born, continuously reared and slaughtered in a country or region classified in accordance with Decision 2007/453/EC as a country or region posing a negligible BSE risk in which there have been no BSE indigenous cases;] (1) or [(b) the meat products contain and are derived from treated intestines sourced from animals which originate from a country or region classified in accordance with Decision 2007/453/EC as a country or region posing a negligible BSE risk in which there has been at least one BSE indigenous case, and: (1) either [(i) the animals were born after the date from which the ban on the feeding of ruminants with meat-and-bone meal and greaves derived from ruminants has been enforced;] (1) or [(i) the treated intestines of bovine, ovine and caprine animal origin do not contain and are not derived from specified risk material as defined in Annex V, point 1, to Regulation (EC) No 999/2001.]]]] (M) Commission Decision 2007/453/EC of 29 June 2007 establishing the BSE status of Member States or third countries or regions thereof according to their BSE risk (OJ L 172, 30.6.2007, p. 84)." (N) https://www.oie.int/en/standard-setting/terrestrial-code/access-online/’;" (b) the following points II.1.13. and II.1.14. are added to the public health attestation after point II.1.12.: ‘(1)(11) [II.1.13. if containing material from farmed cervidae: the product contains or is derived exclusively from meat, excluding offal and spinal cord, of farmed cervid animals which have been examined for chronic wasting disease by histopathology, immunohistochemistry or other diagnostic method recognised by the competent authorities with negative results and is not derived from animals coming from a herd where chronic wasting disease has been confirmed or is officially suspected.] (1)(12) [II.1.14. if containing material from wild cervidae: the product contains or is derived exclusively from meat, excluding offal and spinal cord, of wild cervid animals which have been examined for chronic wasting disease by histopathology, immunohistochemistry or other diagnostic method recognised by the competent authorities with negative results and is not derived from animals coming from a region where chronic wasting disease has been confirmed in the last three years or is officially suspected.]’; (c) points II.2.2. to II.2.4. of the animal health attestation are replaced by the following: ‘(1) either [II.2.2. has been processed from fresh meat from only one species of animals, with code ____ (4), and the fresh meat used for the processing of the meat product has undergone the specific treatment ____(5), which is specifically assigned in Annex XV, Part 1, to Implementing Regulation (EU) 2021/404 to the species of origin of the fresh meat and to the zone referred to in point II.2.1. and has been obtained from animals originating from: (1) either [the zone referred to in point II.2.1.;]] (1) or [the zone with code _____ (6), which, at the date of issue of this animal health/official certificate, is listed for entry into the Union of fresh meat of the species from which the meat product has been processed in (1) either [Annex XIII, Part 1, to Implementing Regulation (EU) 2021/404, in the case of fresh meat of ungulates;]]] (7) (1) or [Annex XIV, Part 1, to Implementing Regulation (EU) 2021/404, in the case of fresh meat of poultry and game birds;]]] (1) or [a Member State;]]] (1) or [II.2.2. has been processed from fresh meat of poultry, with code ____(4), which originate from a zone listed for entry into the Union of fresh meat of poultry where there has been a case or an outbreak of highly pathogenic avian influenza or infection with Newcastle disease virus and the fresh meat used for the processing of the meat product has undergone at least the specific treatment “D”(5);] (1) or [II.2.2. has been processed mixing fresh meat from different species of animals, with codes ____ , ____ , ____(4), and such fresh meat: (1) either [II.2.2.1. has been mixed before the final treatment and, after mixing, has undergone the specific treatment ____(5), as it is the most severe of the treatments specifically assigned in Annex XV, Part 1, to Implementing Regulation (EU) 2021/404 to the different species of origin of the fresh meat and to the zone referred to in point II.2.1., and has been obtained from animals originating from: (1) either [the zone referred to in point II.2.1.]] (1) or [the zone with (1) [code _____(6) which, at the date of issue of this animal health/official certificate, is listed in Annex XIII, Part 1, to Implementing Regulation (EU) 2021/404 for entry into the Union of fresh meat of the species from which the meat product has been processed;](7) (1) [code _____(6) which, at the date of issue of this animal health/official certificate, is listed in Annex XIV, Part 1, to Implementing Regulation (EU) 2021/404 for entry into the Union of fresh meat of the species from which the meat product has been processed;]]] (1) or [a Member State;]] (1) or [II.2.2.1. has been mixed after the final treatment and, before the mixing, has undergone the specific treatment(s) ________, _________, ________(8), as specifically assigned in Annex XV, Part 1, to Implementing Regulation (EU) 2021/404 to the different species of origin of the fresh meat and to the zone referred to in point II.2.1., and has been obtained from animals originating from: (1) either [the zone referred to in point II.2.1.;]] (1) or [the zone with (1) [code ______(6) which, at the date of issue of this animal health/official certificate, is listed in Annex XIII, Part 1, to Implementing Regulation (EU) 2021/404 for entry into the Union of fresh meat of the species from which the meat product has been processed;] (7) (1) [code _____(6) which, at the date of issue of this animal health/official certificate, is listed in Annex XIV, Part 1, to Implementing Regulation (EU) 2021/404 for entry into the Union of fresh meat of the species from which the meat product has been processed;]]] (1) or [a Member State.]] (1) or [II.2.2. has (a) been processed from fresh meat from one species of animals or mixing fresh meat from different species of animals, with codes ____ , ____ , ____(4); (b) been processed from fresh meat obtained from animals originating from the zone/s with code/s ______, _____ , _____(3) which, at the date of issue of this animal health/official certificate, is/are listed in Annex XV, Part 1, to Implementing Regulation (EU) 2021/404 for entry into the Union of meat products subject to the application of one of the specific treatments defined in Annex XXVI to Commission Delegated Regulation (EU) 2020/692 (O) to the fresh meat of the relevant species; (c) undergone the specific ‘treatment B’ (5);] II.2.3. has been processed from fresh meat obtained from: (1) either [animals kept in an establishment that was not subject to national restriction measures for animal health reasons, including the relevant listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 and emerging diseases at the time of dispatch of the animals to the slaughterhouse and in and around the establishment, in an area of 10 km radius, including where appropriate the territory of a neighbouring country, such diseases have not been reported during the period of 30 days prior to the date of dispatch of the animals to the Union;] (1) or [wild animals which originate from a place in and round which none of the listed diseases relevant for the species of origin of the meat products in accordance with Annex I to Commission Delegated Regulation (EU) 2020/692, has been reported during the period of 30 days prior to the date of dispatch of the meat product to the Union;], II.2.4. after processing, has been handled until packaging in a way to prevent cross contamination that could introduce an animal health risk; (9) [II.2.5. is intended for a Member State which has been granted the status free from infection with Newcastle disease virus without vaccination in accordance with Commission Delegated Regulation (EU) 2020/689 (P), and has been obtained from poultry that have not been vaccinated against infection with Newcastle disease virus with a live vaccine during the period of 30 days prior to the date of slaughter]. (O) Commission Delegated Regulation (EU) 2020/692 of 30 January 2020 supplementing Regulation (EU) 2016/429 of the European Parliament and of the Council as regards rules for entry into the Union, and the movement and handling after entry of consignments of certain animals, germinal products and products of animal origin (OJ L 174, 3.6.2020, p. 379)" (P) Commission Delegated Regulation (EU) 2020/689 of 17 December 2019 supplementing Regulation (EU) 2016/429 of the European Parliament and of the Council as regards rules for surveillance, eradication programmes, and disease-free status for certain listed and emerging diseases (OJ L 174, 3.6.2020, p. 211).’;" (d) the following Footnotes (11) and (12) are added to the Notes to Part II, after footnote (10): ‘(11) Applicable when the meat has been obtained from a country mentioned in Annex IX, Chapter F, point 1, to Regulation (EC) No 999/2001. (12) Applicable when the meat has been obtained from a country mentioned in Annex IX , Chapter F, point 2, to Regulation (EC) No 999/2001.’;